Related by context. All words. (Click for frequent words.) 77 plus dexamethasone 75 FOLFOX4 75 stage IIIb IV 75 VELCADE melphalan 75 5 FU leucovorin 75 plus prednisone prednisolone 75 mitoxantrone plus 74 lopinavir r 74 ACTEMRA TM 74 comparator arm 73 alfa 2a 73 infliximab monotherapy 73 FOLFIRI 73 8mg/kg 73 dacarbazine 73 Xeloda ® 72 chlorambucil 72 melphalan prednisone 72 docetaxel chemotherapy 72 Peg IFN 72 pegylated interferon alpha 72 carboplatin paclitaxel 72 metastatic castration resistant 72 metastatic hormone refractory 72 Fludara 72 Folfox 72 Doxil ® 71 FOLFOX 71 gemcitabine carboplatin 71 receiving prophylactic anticoagulation 71 irbesartan 71 estramustine 71 irinotecan doxorubicin oxaliplatin paclitaxel 71 Peginterferon 71 FEMALES SHOULD BE ADVISED 71 placebo dexamethasone 71 sorafenib Nexavar 71 trastuzumab Herceptin R 71 Taxotere ® 71 5 fluorouracil leucovorin 71 TO AVOID PREGNANCY WHILE 71 Ixempra 70 candesartan cilexetil 70 evaluating tivozanib 70 cyclophosphamide doxorubicin vincristine 70 refractory chronic lymphocytic 70 plus gemcitabine 70 5-FU/LV 70 FOLFOX6 chemotherapy regimen 70 PEGINTRON TM 70 5 Fluorouracil 70 low dose cytarabine 70 cyclophosphamide methotrexate 70 FOLFOX4 alone 70 pegylated interferon peg IFN 70 Aflibercept 70 abacavir lamivudine 70 sorafenib tablets 70 mg qd 70 FUSILEV enhances 70 pegylated interferon alfa 2b 70 R sorafenib tablets 70 interferon gamma 1b 70 mg TID 70 doxorubicin cyclophosphamide 70 pegylated interferon alfa 2a 70 cetuximab Erbitux R 70 sunitinib Sutent 70 PegIFN 70 erlotinib Tarceva ® 70 anthracycline taxane 69 ribavirin RBV 69 paclitaxel carboplatin 69 mapatumumab 69 mRCC 69 dasatinib Sprycel ® 69 IFN alfa 69 ritonavir boosted 69 standard chemotherapy regimen 69 relapsed multiple myeloma 69 achieved ACR# 69 CIMZIA TM 69 cisplatin gemcitabine 69 pegylated interferon alpha 2a 69 oral ridaforolimus 69 active comparator 69 docetaxel Injection Concentrate 69 relapsed refractory multiple myeloma 69 adriamycin 69 recurrent NSCLC 69 mcg QD 69 capecitabine Xeloda 69 docetaxel Taxotere R 69 telaprevir dosed 69 oxycodone CR 69 PREZISTA r 69 oblimersen 69 SPRYCEL ® 69 galiximab 69 FOLFOX6 69 Pegasys ® 69 R# #mg BID 69 Median PFS 69 naïve HCV 69 cyclophosphamide chemotherapy 69 prednisone prednisolone plus 69 peginterferon alfa 2b 69 INSPIRE Trial Phase III 69 plus COPEGUS 69 daunorubicin 69 plus ribavirin 68 epirubicin cyclophosphamide 68 MAGE A3 ASCI 68 mg QD 68 prostate cancer HRPC 68 pegylated liposomal doxorubicin 68 unresectable Stage III 68 nicardipine 68 metastatic HRPC 68 dalteparin 68 #mg q8h 68 COPEGUS 68 equi analgesic doses 68 neurologic progression 68 AVASTIN 68 saline placebo 68 Taxotere R 68 Camptosar ® 68 IMiDs 68 Newly Diagnosed Multiple Myeloma 68 ULORIC 68 Meets Primary Endpoint 68 PEG interferon 68 R lenalidomide 68 IIIa inhibitor 68 CIMZIA TM certolizumab pegol 68 mg BID 68 infusional 5-FU/LV 68 Gemzar ® 68 docetaxel prednisone 68 Zometa hazard 68 #mg BID [001] 68 peginterferon alfa 2a 68 vinorelbine 68 docetaxel Taxotere ® 68 interferon alfa 2a 68 TAXOTERE R 68 #.#mg/dL 68 ritonavir boosted atazanavir 68 peginterferon alfa 2a Pegasys 68 ® lenalidomide 68 bevacizumab Avastin R 68 Navelbine ® 68 docetaxel Taxotere 68 mycophenolate mofetil 68 unfractionated heparin UFH 68 aspirin heparin 68 relapsed MM 68 dacarbazine DTIC 68 irinotecan containing 68 Tarceva TM 68 lenalidomide Revlimid R 68 metastatic GIST 68 peg IFN 68 mcg kg 68 plus DOXIL 68 budesonide pMDI 67 #mg BID [003] 67 humanized interleukin 6 67 Free Survival PFS 67 interferon ribavirin 67 clodronate 67 temsirolimus 67 plus OBT 67 AEGR 67 bortezomib Velcade R 67 alpha 2b 67 efavirenz EFV 67 plus methotrexate 67 oral clodronate 67 novel synthetic PEGylated 67 receiving INTRON 67 Interferon alfa 2b 67 bevacizumab Avastin ® 67 monoclonal antibody IgG1 Mab 67 CCX# B 67 FOLPI 67 sunitinib malate 67 metastatic colorectal carcinoma 67 Ovitrelle R Serostim 67 #mg QD [002] 67 virus HCV protease inhibitor 67 q#h 67 vincristine doxorubicin 67 alpha 2a 67 Flu Cy 67 Pemetrexed 67 weekly subcutaneous injections 67 PEGASYS ® 67 mitoxantrone 67 interferon alfa 67 5-fluorouracil/leucovorin 67 Hormone Refractory Prostate Cancer 67 XELOX 67 lispro 67 gemcitabine Gemzar 67 bendamustine 67 interferon beta 1a infertility 67 #mg/m# [001] 67 Medoxomil 67 peginterferon alpha 2a 67 ZOLINZA 67 Platinol ® cisplatin 67 HER2 positive metastatic breast 67 metastatic renal cell carcinoma 67 CLARITY study 67 refractory multiple myeloma 67 ATACAND 67 anthracyclines taxanes 67 oral rivaroxaban 67 EFAPROXYN 67 mg m² 67 stage IIIB 67 Femara letrozole 67 dextromethorphan quinidine 67 cetuximab Erbitux ® 67 Neulasta R 67 PEG Intron 67 Relapsed Refractory 67 gemcitabine cisplatin 67 ribavirin therapy 67 Peginterferon alfa 2b 67 bone marrow reticulin deposition 67 Pegasys plus Copegus 67 tenofovir emtricitabine 67 HCV RESPOND 2 67 recurrent GBM 67 DOXIL 67 pertuzumab 67 primary hypercholesterolemia 67 induced macular edema 66 titrated glipizide 66 R Saizen R 66 Irinotecan 66 aflibercept VEGF Trap 66 RLAI 66 Trial Evaluating 66 oral chemotherapeutic agent 66 Zorbtive TM 66 postmenopausal osteoporotic women 66 Jevtana 66 Amrubicin 66 Hycamtin ® 66 Taxotere chemotherapy 66 PegIFN RBV 66 FOLFIRI alone 66 dose cytarabine 66 log# IU mL 66 Acetate Rectal Suppositories 66 metastatic castrate resistant 66 certolizumab 66 SYNERGY Stent 66 custirsen 66 lintuzumab SGN 66 subcutaneously administered 66 chemotherapy fludarabine 66 Fludara ® 66 Fulvestrant 66 nab paclitaxel 66 unresectable stage 66 adalimumab Humira 66 idarubicin 66 elotuzumab 66 Platinol 66 NOXAFIL Oral Suspension 66 pegylated interferon alfa 66 dose dexamethasone 66 Alkeran 66 azacitidine 66 paclitaxel Taxol ® 66 Capecitabine 66 azilsartan medoxomil 66 interferon alfa 2b 66 metastatic CRPC 66 evaluating picoplatin 66 cisplatin vinorelbine 66 non splenectomized 66 dasatinib Sprycel 66 iniparib 66 CHOP chemotherapy 66 EGFR expressing mCRC 66 hormone refractory metastatic prostate 66 gemcitabine chemotherapy 66 TELINTRA 66 cyclophosphamide doxorubicin 66 everolimus eluting stents 66 dexamethasone Decadron 66 BARACLUDE ® 66 drotrecogin alfa activated 66 relapsed myeloma 66 mg/m2 administered 66 Oral Fingolimod 66 Copegus ® 66 neoadjuvant 66 metaglidasen 66 refractory CLL 66 pegylated interferons 66 AVONEX ® 66 ABVD 66 decitabine 66 metastatic CRC 66 oral deforolimus 66 goserelin 66 beta 1a 66 ALN HPN 66 REVLIMID R 66 splenectomized 66 mg q#h 66 AAG geldanamycin analog 66 novel VDA molecule 66 Pegylated Interferon 66 3mg/kg 66 progression TTP 66 somatostatin analog 66 sorafenib Nexavar ® 66 leukemia CLL 66 aflibercept 66 lopinavir r arm 66 Torisel 66 chemotherapy gemcitabine 66 PegIntron 66 CYPHER Stent 66 FluCAM 66 4mg/kg 66 q8h 66 prednisone CHOP 66 Platinol ® 66 achieved CCyR 66 oral diclofenac 66 Randomized Phase 66 Pharmacokinetics PK 66 Patients Treated With 66 HBeAg negative patients 66 gefitinib Iressa 65 intravesical infusion therapy 65 vandetanib 65 EPIVIR 65 previously untreated follicular 65 unresectable locally advanced 65 subcutaneous enoxaparin 65 mg RDEA# 65 mcg kg REBETOL 65 Engerix B 65 demonstrated antitumor activity 65 PEG IFN 65 ZACTIMA 65 PEGylated anti 65 free survival PFS 65 Telik logo TELINTRA 65 evaluating Actimmune 65 relapsed CLL 65 docetaxel 65 bortezomib refractory 65 5 fluorouracil 65 Zevalin R Ibritumomab 65 liposomal formulation 65 Dementia Related Psychosis 65 recurrent glioblastoma multiforme 65 placebo p = 65 Median progression 65 Mg Uk 65 lenalidomide Revlimid ® 65 aspirin clopidogrel 65 multiple myeloma MM 65 XIENCE V PROMUS Stent 65 assessing T DM1 65 hyperphenylalaninemia HPA due 65 Ticagrelor 65 liposome injection 65 Dacogen injection 65 μg dose 65 peg interferon 65 median PFS 65 plus dacarbazine 65 Copegus ribavirin 65 irinotecan cisplatin 65 APTIVUS r 65 Mg Usa 65 chemotherapy FOLFOX 65 REYATAZ r 65 carcinoma mCRC 65 mcg BID 65 BEACOPP 65 relapsing multiple sclerosis 65 HGS ETR2 65 Clolar ® 65 vapreotide acetate 65 Contrave# 65 Temsirolimus 65 palifermin 65 RANK Ligand inhibitor 65 PROCTOCORT R 65 plus GP IIb 65 MabCampath 65 venlafaxine XR 65 Lenalidomide 65 CANCIDAS 65 peginterferon alfa 65 metastatic pancreatic 65 mTOR inhibitor 65 Dabigatran etexilate 65 urinary N telopeptide 65 Navelbine 65 Neoadjuvant 65 Peginterferon Alfa 2a 65 oxymorphone ER 65 Xelox 65 GOUT 65 gemcitabine Gemzar ® 65 Telintra 65 PEGylated Fab fragment 65 mcg albinterferon alfa 2b 65 fosamprenavir 65 Randomized Phase II 65 mg/m2 dose 65 Capesaris 65 Pharmacokinetic parameters 65 lumiliximab 65 ARIMIDEX 65 Peginterferon alfa 2a 65 BENICAR HCT 65 #mg/m# [002] 65 de novo kidney transplant 65 alfuzosin 65 known dihydropyrimidine dehydrogenase 65 angiotensin converting enzyme inhibitor 65 BCG refractory carcinoma 65 desvenlafaxine succinate 65 refractory NSCLC 65 Aptivus ® 65 doxazosin 65 paclitaxel Taxol 65 carboplatin chemotherapy 65 pan histone deacetylase 65 PROCTOCORT ® Suppository Hydrocortisone 65 NATRECOR R 65 asymptomatic metastatic 65 EURIDIS 65 paclitaxel cisplatin 65 Nexavar ® 65 Chronic Hepatitis C 65 PEG INTRON R 65 tirofiban 65 Sanofi Aventis Taxotere 65 erlotinib Tarceva R 65 Sirolimus eluting Coronary Stent 65 pemetrexed 65 visilizumab 65 mg tid 65 brand ciclesonide HFA 65 mg subcutaneous 65 following fluoropyrimidine oxaliplatin 65 vinca alkaloid 65 clopidogrel Plavix 65 Elitek 65 antiretroviral naïve 65 lexidronam injection 65 Randomized Double blind 65 pioglitazone HCl 65 daily Infergen 65 plus glycoprotein IIb 65 Ceplene/IL-2 65 chemoradiation therapy 65 adjunctive placebo 65 CTAP# Capsules 65 FASLODEX 65 receiving PEGINTRON 65 lumbar spine BMD 65 dapagliflozin plus 65 Bezielle 65 LEXIVA r 65 pharmacologically active isomer 65 By JENNIFER LEARN 65 Pegasys peginterferon alfa 2a 65 levosimendan 65 mg ustekinumab 65 salmeterol fluticasone 65 IFN α 65 fluvastatin 65 FIRMAGON 65 Sandostatin R 65 gemcitabine 65 Study Evaluating 64 adefovir 64 angiotensin receptor blocker ARB 64 CIMZIA ™ 64 pain palliation 64 WBRT alone 64 forodesine 64 Tipranavir 64 Melphalan 64 CRp 64 phase IIb clinical 64 doxorubicin HCl liposome injection 64 mg hydrochlorothiazide 64 castrate resistant prostate cancer 64 fludarabine 64 Adjuvant Treatment 64 prednisone VcMP 64 + PH# 64 Neupogen ® 64 potent CYP#A# inhibitors 64 R Bortezomib 64 BENICAR 64 ARCOXIA 64 paclitaxel Taxol R 64 axitinib 64 BCIRG 64 Pertuzumab 64 folinic acid FA 64 tamsulosin 64 abiraterone acetate 64 TORISEL 64 KRN# 64 ® bortezomib 64 TLUS 64 refractory AML 64 FOLFOX regimen 64 morphometric vertebral fractures 64 dacarbazine chemotherapy 64 Heterozygous Familial Hypercholesterolemia 64 TAXUS Express Stent 64 Ophena TM 64 oral prodrug 64 6R BH4 64 low dose Iluvien 64 rosuvastatin #mg 64 arsenic trioxide injection 64 Targretin 64 olanzapine risperidone 64 cyclophosphamide vincristine 64 VcMP 64 recurrent metastatic ovarian cancer 64 HRPC 64 PREZISTA ritonavir 64 unresectable tumors 64 Relapsed Multiple Myeloma 64 rituximab refractory 64 annualized relapse 64 baminercept 64 HBeAg + 64 #mg QD [001] 64 pegylated alpha interferon 64 methotrexate monotherapy 64 posaconazole 64 TAXUS Liberte Long 64 Temodar ® 64 LymphoStat B belimumab 64 azathioprine 64 DOXIL ® 64 fluoropyrimidine 64 Fludarabine 64 patients coinfected 64 TYKERB 64 chemotherapy cisplatin 64 Pivotal Phase III 64 fludarabine cyclophosphamide 64 octreotide LAR 64 HMG CoA reductase inhibitor 64 Taxotere docetaxel 64 HBeAg positive patients 64 ug kg 64 COMBIVIR 64 Relapsing Multiple Sclerosis 64 davunetide intranasal AL 64 concurrent chemoradiation 64 pomalidomide 64 R adefovir dipivoxil 64 balsalazide disodium Capsules 64 liposomal doxorubicin 64 colesevelam HCl 64 Vidaza ® 64 xanthine oxidase inhibitor 64 CHAMPION PCI 64 pamidronate 64 alvimopan 64 Panzem R NCD 64 mCRC patients 64 zalutumumab 64 pegylated interferon 64 Imprime PGG 64 Epothilone D 64 Prograf ® 64 Epirubicin 64 non nucleoside inhibitor 64 Refractory Hodgkin Lymphoma 64 serotonin norepinephrine reuptake inhibitor 64 paclitaxel poliglumex 64 bosutinib 64 oxaliplatin Eloxatin 64 Paraplatin ® 64 pegylated liposomal doxorubicin PLD 64 tipranavir r 64 Ziprasidone 64 insulin detemir 64 NSABP B 64 metastatic RCC 64 CRESTOR #mg 64 Targretin capsules 64 related DHFR inhibitors 64 Bosutinib 64 zoledronate 64 familial amyloidotic polyneuropathy FAP 64 AGILECT R 64 thymalfasin 64 paclitaxel chemotherapy 64 hydroxymethyl coenzyme 64 atazanavir ritonavir 64 Vildagliptin 64 placebo PBO 64 TTF Therapy 64 Bevacizumab 64 metastatic ocular 64 Initiate Phase 64 HBeAg seroconversion 64 refractory metastatic colorectal cancer 64 alvespimycin 64 sunitinib Sutent ® 64 Cyclophosphamide 64 AIR CF1 64 cell lymphoma CTCL 64 administered subcutaneously 64 Cutaneous T 64 melphalan 64 3 registrational trial 64 APTIVUS R 64 Adjunctive Therapy 64 cabazitaxel 64 Acute Ischemic Stroke 64 evaluating satraplatin plus 64 evaluating REVLIMID 64 myelodysplastic myeloproliferative diseases 64 COLAZAL R 64 EDEMA3 64 DEB# 64 BUPHENYL R sodium phenylbutyrate 64 tocilizumab 64 fluorouracil 64 low dose dexamethasone 64 protease inhibitor PI 64 Pegasys R 64 Certolizumab 64 Intravitreal 63 evaluating satraplatin 63 topical gel formulation 63 YERVOY 63 adenosine injection 63 CCyR 63 bosentan 63 HGS ETR1 mapatumumab 63 Sandostatin 63 Hsp# Inhibitor 63 Known hypersensitivity 63 CALGB # [002] 63 cytarabine daunorubicin 63 HMG CoA reductase inhibitors 63 Suppository Hydrocortisone Acetate Rectal 63 ELACYT 63 octreotide acetate 63 methylnaltrexone bromide 63 bendamustine ifosfamide 63 ancrod 63 Gemcitabine 63 tumors GIST 63 -#.# mg dL [001] 63 mg/m2 IV 63 orally administered inhibitor 63 modified glutathione analog 63 achieved PASI 63 valsartan 63 R darbepoetin alfa 63 CR CRu 63 REBETOL 63 apremilast 63 Herceptin trastuzumab 63 Improved Progression 63 Copegus 63 cinacalcet HCl 63 deep venous thromboses 63 NEUPOGEN R 63 Diovan Exforge Tekturna Zelnorm 63 * olmesartan medoxomil 63 oral vancomycin 63 SVR# 63 Sandostatin LAR Depot 63 postoperative chemotherapy 63 squamous histology 63 maximally tolerated dose 63 treatment naïve genotype 63 miconazole Lauriad ® 63 tapentadol ER 63 glycoprotein IIb IIIa inhibitor 63 oral Hycamtin 63 pharmacodynamics PD 63 CR nPR 63 calcineurin inhibitor 63 Stage IIIB IV 63 refractory cutaneous T 63 TNF Tumor Necrosis Factor 63 ENL recurrence 63 combines bupropion 63 5 FU capecitabine 63 tanespimycin 63 folinic acid 63 R rilonacept Injection 63 TAXUS p value 63 DU #b 63 nilotinib 63 cyclophosphamide FC 63 metformin sulfonylurea 63 RoACTEMRA 63 vinorelbine tartrate 63 oxycodone IR 63 PSMA ADC 63 antithymocyte globulin 63 doxorubicin docetaxel 63 leukemia AML 63 mg administered orally 63 CTA# Injection 63 ALIMTA cisplatin 63 Hazard Ratio 63 febuxostat 63 oral antidiabetic medication 63 mcg dose 63 urocortin 2 63 ARCALYST ® 63 everolimus tablets 63 Paraplatin 63 bicalutamide 63 advanced metastatic renal 63 placebo controlled clinical 63 basal bolus regimen 63 BRIM2 63 Severe Sepsis 63 ezetimibe simvastatin 63 CD3 monoclonal antibody 63 ribavirin USP 63 Romiplostim 63 IFL chemotherapy regimen 63 novel orally inhaled 63 COPEGUS ribavirin 63 oral picoplatin 63 pharmacokinetic equivalence 63 ISENTRESS 63 idraparinux 63 fenofibric acid 63 mg kg dose 63 luteinizing hormone releasing 63 huN# DM1 63 Q2W 63 leucovorin 63 anastrazole 63 3TC lamivudine Epivir 63 registrational Phase 63 1mg 2mg 63 PEG Interferon alfa 63 amprenavir 63 degarelix 63 generation Hsp# inhibitor 63 achieved sustained virologic 63 Novel Oral 63 fondaparinux 63 Phase 2b Clinical Trial 63 PEG SN# 63 imatinib therapy 63 IV NSCLC 63 BARACLUDE R 63 #mg/day [002] 63 ularitide 63 Syncria R 63 multicenter Phase III 63 omega interferon 63 Phase Ib clinical trials 63 Pegintron 63 comparing XIENCE V 63 zonisamide SR 63 tolterodine ER 63 PEG INTRON 63 Interferon beta 1a 63 atrial fibrillation budiodarone ATI 63 Antitumor Activity 63 Degarelix 63 Brentuximab Vedotin SGN 63 occlusion PAO 63 NATRECOR ® 63 tumor activated prodrug 63 mg kg BID 63 parecoxib 63 carboplatin 63 mycophenolate mofetil MMF 63 tiotropium 63 plus MTX 63 IMiDs ® 63 Lantus ® 63 Zenvia ™ 63 Azacitidine 63 rosuvastatin Crestor 63 stage IIIb 63 abacavir sulfate lamivudine 63 EOquin TM phase 63 Abiraterone Acetate 63 atorvastatin #mg 63 Pegylated interferon 63 MGd 63 cancer mCRC 63 beta2 agonist 63 adefovir dipivoxil 63 fulvestrant 63 DAPT 63 biochemical relapse 63 glufosfamide 63 nucleoside naive 63 PRN FDA Approves 63 ribavirin Copegus ® 63 mg p = 63 malignancy HCM 63 catheter occlusion 63 Daclizumab 63 peginterferon alfa 2a #KD 63 pharmacodynamic properties 63 analgesic efficacy 63 flutamide 63 PROCRIT ® 63 panitumumab Vectibix R 63 fallopian tube carcinoma 63 capecitabine 63 GP IIb IIIa inhibitors 63 Pivotal Phase 63 Phase IIb Clinical Trial 63 limiting toxicity DLT 63 risedronate sodium tablets 63 Advanced Melanoma 63 #mg doses [002] 63 peginterferon 63 ixabepilone 63 Myelodysplastic Syndrome MDS 63 viral kinetics 63 noninferior 63 GW# [003] 63 IL# PE#QQR 63 microbiological eradication 63 Tarceva erlotinib 63 IV Busulfex 63 nilotinib Tasigna ® 63 Halaven 63 FROVA 63 REVIVE Diabetes 63 Paliperidone Palmitate 63 adult chronic ITP 63 sipuleucel T 63 COPEGUS R 63 Sustained virologic response 63 tenofovir disoproxil fumarate 63 R tenofovir disoproxil 63 bleeding pallor 63 Taxol paclitaxel 63 generation purine nucleoside 63 Inhalation Aerosol 63 TAXUS ® 63 Castration Resistant Prostate Cancer 63 systemic anaplastic large 63 AVOREN 63 memantine HCl 63 oral ribavirin 63 antibody MAb 63 retinal vein occlusion induced 63 RECORD1 63 reduce serum phosphate 63 gemtuzumab ozogamicin 63 sargramostim 63 TMC# C# 63 anthracycline containing 63 plus glimepiride 62 Intervention Effectiveness 62 PEGylated interferon beta 1a 62 #ug [001] 62 Gemzar gemcitabine 62 CYT# potent vascular disrupting 62 Raptiva r 62 novel emulsion formulation 62 NEVO ™ 62 ISTODAX ® 62 monotherapy 62 piperacillin tazobactam 62 paclitaxel eluting stents 62 Oral NKTR 62 tipranavir 62 sitaxsentan 62 INTEGRILIN ® 62 REVLIMID ® 62 PNP inhibitor 62 Copegus R 62 sunitinib 62 severe renal impairment 62 RECIST Response Evaluation Criteria 62 5FU 62 Luveris R Ovidrel R 62 basiliximab 62 investigational pharmacologically unique 62 icatibant 62 IRESSA 62 Naive Patients 62 biphasic insulin aspart 62 Octreolin 62 eribulin 62 R pramlintide acetate 62 Bortezomib 62 remission induction 62 valopicitabine 62 R ribavirin USP 62 recurrent malignant glioma 62 amoxicillin clavulanate 62 R metformin Concor 62 Controlled Trial 62 Ozarelix 62 octreotide implant 62 Danazol 62 Taxus Stent 62 panitumumab Vectibix 62 prostate cancer CRPC 62 Combination REOLYSIN R 62 Cloretazine ® 62 DexaSite 62 #.#/#.# mmHg [001] 62 VEGFR2 inhibitor 62 -#.# log# 62 worsening thrombocytopenia 62 regorafenib 62 adalimumab 62 boosted protease inhibitor 62 humanized therapeutic 62 TELCYTA 62 mycophenolic acid 62 mg simvastatin 62 TYGACIL 62 NPH insulin 62 Lucentis monotherapy 62 dependent kinase inhibitor 62 Omacetaxine 62 methylergonovine 62 WBRT plus 62 CYP#A# substrate 62 ug dose 62 Raptiva ® 62 Taxol ® 62 relapsing remitting MS RRMS 62 Cleviprex TM clevidipine 62 hormone refractory prostate cancer 62 Cream USP 1 62 lumbar spine bone 62 FOLOTYN ® 62 sapropterin dihydrochloride 62 TNF antagonist 62 treatment naive genotype 62 MEK Inhibitor 62 Achieves Primary Endpoint 62 EGFR TKI 62 LPV r 62 Apidra ® 62 Granted Orphan Drug 62 KRAS mutant tumors 62 Pazopanib 62 unique alkylating agent 62 APTIVUS 62 investigational antiplatelet agent 62 metformin HCl 62 DOXIL R 62 RG# [001] 62 potent triglyceride lowering 62 intravenous bolus 62 Xeloda capecitabine 62 splenectomized patients 62 trastuzumab Herceptin ® 62 cell carcinoma RCC 62 delivers fluocinolone acetonide FA 62 Amgen Neulasta ® 62 peptidic compound 62 IMiDs ® compound 62 Rebif ® 62 radiotherapy RT 62 Nexavar sorafenib 62 clinical trials Archexin 62 Phase IIIb clinical 62 AzaSite Plus 62 bupropion SR 62 untreated multiple myeloma 62 olmesartan 62 Budesonide foam crofelemer 62 capecitabine Xeloda R